400 results on '"Sbiera, Silviu"'
Search Results
52. Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
53. High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
54. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer
55. Circulating microRNA Expression in Cushing's Syndrome
56. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser\(^{114}\) phosphorylation
57. Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
58. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden
59. Consecutive development of adrenal Cushing´s syndrome and Cushing´s disease in a female patient with somatic CTNNB1, USP8, and NR3C1 mutations
60. Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas
61. Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushingʼs Syndrome
62. Circulating microRNA Expression in Cushing’s Syndrome
63. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser 114 phosphorylation
64. Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation
65. Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations
66. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
67. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
68. The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight
69. Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals
70. Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis
71. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights
72. Differential adrenal toxicity of SOAT1-inhibitors
73. Cytochrome P450 (CYP) 2W1 affect steroid secretion in adrenocortical cell line and tumor tissues
74. Immune infiltrate and PD-1 / PD-L1 expression in adrenocortical carcinoma: who can predict patients´ outcome?
75. Is there an epithelial to mesenchymal transition (EMT) in adrenocortical tumours?
76. RNA-sequencing of adrenocortical tumors reveals novel pathogenetic insights
77. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study
78. Correction: Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain
79. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
80. Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain
81. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
82. SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
83. Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
84. Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
85. Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
86. High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors
87. Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging
88. Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma
89. Driver mutations in USP8 wild-type Cushing's disease
90. Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma
91. Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma
92. ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
93. Driver mutations in USP8 wild-type Cushing’s disease
94. Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma
95. Steroid hormones and cancer immunity - insights into adrenocortical carcinoma
96. Characterization of cell death induced by mitotane in adrenocortical carcinoma cells
97. SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
98. SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells
99. Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease
100. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.